423Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
China
Neuroscience Intelligence
China neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #4 of 50 · Data maturity A · Research score 52.1 · Data confidence 100.0 / 100 · Snapshot 2026-10-29 06:18 UTC.
147Recruiting trials
1,590Publications
523Institutions
Executive interpretation
China ranks #4 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. Clinical metrics and NCT evidence use only records classified as in_scope or related; out_of_scope records remain preserved outside these analytical counts. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC158 recruiting
Xuanwu Hospital, Beijing1410 recruiting
Beijing Tiantan Hospital135 recruiting
Shanghai Mental Health Center134 recruiting
Xijing Hospital132 recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine112 recruiting
Children's Hospital of Fudan University115 recruiting
Ruijin Hospital104 recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine94 recruiting
Hoffmann-La Roche72 recruiting
Disease activity
Parkinsons66trials
Stroke63trials
Alzheimers44trials
Epilepsy41trials
Autism31trials
Depression27trials
Adhd24trials
Other Neurology24trials
Multiple Sclerosis13trials
Schizophrenia12trials
Research institutions
Beijing Shijitan HospitalOpenAlexlinked institution
Kowloon HospitalOpenAlexlinked institution
BGI Group (China)OpenAlexlinked institution
Tsinghua Shenzhen International Graduate SchoolOpenAlexlinked institution
Southwest Petroleum UniversityOpenAlexlinked institution
Sichuan Agricultural UniversityOpenAlexlinked institution
Shaanxi Provincial People's HospitalOpenAlexlinked institution
Shantou University Mental Health CenterOpenAlexlinked institution
Second Hospital of Hebei Medical UniversityOpenAlexlinked institution
Xi’an Jiaotong-Liverpool UniversityOpenAlexlinked institution
Clinical evidence trail
NCT07830277Drug-Coated Balloon vs Aggressive Medical Management for High-Risk Symptomatic Intracranial Atherosclerotic StenosisNOT_YET_RECRUITING
NCT07811778Transcutaneous Electrical Acupoint Stimulation Combined With Exposure and Response Prevention in the Treatment of Patients With Obsessive-Compulsive Disorder: A Randomized Controlled TrialNOT_YET_RECRUITING
NCT07801014The Impact of Dexmedetomidine Nasal Spray on Perioperative Anxiety in Neurosurgical PatientsNOT_YET_RECRUITING
NCT07790224Multi-Parameter Temporal Interference Stimulation in Patients With Epilepsy Undergoing SEEG MonitoringNOT_YET_RECRUITING
NCT07784088Implantable Wireless Brain-Computer Interface Systems in Patients With TetraplegiaRECRUITING
NCT07754942Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel OcclusionNOT_YET_RECRUITING
NCT07752784Evaluate the Concordance Between PET Imaging of [18F]-APN-1607 Injection and Postmortem Brain Tissue Tau Pathology in Individuals With HV and MCI or AD.RECRUITING
NCT07730762A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During PregnancyACTIVE_NOT_RECRUITING
NCT07721688Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's DiseaseRECRUITING
NCT07692022Social Cognition in Children and Adolescents With Autism Spectrum DisorderACTIVE_NOT_RECRUITING
Research evidence trail
PUBMEDMultidimensional Microstate Alterations and Interpretable Classification of Electrical Status Epilepticus During Sleep Using Multi-Channel EEG.2027-03-01
PUBMEDAn accessible digital single-molecule sensing platform for plasma P-tau217 quantification in Alzheimer's disease screening.2027-02-15
PUBMEDGut microbial histamine and serotonin promote cerebrovascular angiogenesis: Evidence from moyamoya disease.2027-02-01
PUBMEDSimultaneous and ultrasensitive detection of Alzheimer's disease blood biomarkers using magnetic SERS-encoded tags-based LFIA assay.2027-02-01
PUBMEDA signal-locked clamped hybridization chain reaction nanoamplifier for rapid and highly sensitive analysis of Aβ42.2027-02-01
PUBMEDShugan Tongbian Decoction ameliorates constipation and mental disorder by inhibiting UPRmt via Wnt/Retromer axis.2027-01-30
PUBMEDNovel natural inhibitor Rubimaillin targets NLRP3 R167/Y381 to ameliorate inflammatory and neurodegenerative diseases.2027-01-30
PUBMEDCoupled NIR-II fluorescence and mass spectrometry imaging of H2S-associated redox dysregulation in Parkinsonian models.2027-01-15
PUBMEDThe gut-liver-brain axis in alcohol use disorder: The emerging role of bile acid dysregulation.2027-01-05
PUBMEDMapping intrinsic neural timescale alterations in first-episode, drug-naïve adolescent-onset schizophrenia.2027-01-05
PUBMEDWhy the body matters in major depressive disorder: Neuroimaging findings of somatic symptoms and ongoing challenges.2027-01-05
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. Latest collection in this report: 2026-10-24 04:18 UTC. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.